Listed

Tenaya Therapeutics, Inc.

TNYANasdaqCIK 1858848HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.1m, Q2 FY2026
Operating income−$44.1m, Q2 FY2026
Net income−$43.4m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reported0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figurenot reportednot reported0.2Revenue, Q1 FY2026, three months to 2026-03-31$225.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure1.1Revenue, Q2 FY2026, three months to 2026-06-30$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure
Research and development$m23.1Research and development, Q3 FY2023, three months to 2023-09-30$23.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122359.Report this figure22.9Research and development, Q4 FY2023, three months to 2023-12-31$22.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-10, accession 0000950170-25-036329. Derived: 12-month figure less the 9-month figure.Report this figure25.1Research and development, Q1 FY2024, three months to 2024-03-31$25.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-07, accession 0000950170-25-065741.Report this figure22.6Research and development, Q2 FY2024, three months to 2024-06-30$22.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0000950170-25-104182.Report this figure20.4Research and development, Q3 FY2024, three months to 2024-09-30$20.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure18.7Research and development, Q4 FY2024, three months to 2024-12-31$18.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-11, accession 0001193125-26-102252. Derived: 12-month figure less the 9-month figure.Report this figure21.1Research and development, Q1 FY2025, three months to 2025-03-31$21.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure17.4Research and development, Q2 FY2025, three months to 2025-06-30$17.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure15.4Research and development, Q3 FY2025, three months to 2025-09-30$15.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure14.8Research and development, Q4 FY2025, three months to 2025-12-31$14.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-11, accession 0001193125-26-102252. Derived: 12-month figure less the 9-month figure.Report this figure14.8Research and development, Q1 FY2026, three months to 2026-03-31$14.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure16.6Research and development, Q2 FY2026, three months to 2026-06-30$16.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure
Operating income$m(30.9)Operating income, Q3 FY2023, three months to 2023-09-30−$30.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122359.Report this figure(31.4)Operating income, Q4 FY2023, three months to 2023-12-31−$31.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-10, accession 0000950170-25-036329. Derived: 12-month figure less the 9-month figure.Report this figure(33.8)Operating income, Q1 FY2024, three months to 2024-03-31−$33.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-07, accession 0000950170-25-065741.Report this figure(30.8)Operating income, Q2 FY2024, three months to 2024-06-30−$30.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0000950170-25-104182.Report this figure(26.7)Operating income, Q3 FY2024, three months to 2024-09-30−$26.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure(24.7)Operating income, Q4 FY2024, three months to 2024-12-31−$24.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-11, accession 0001193125-26-102252. Derived: 12-month figure less the 9-month figure.Report this figure(27.5)Operating income, Q1 FY2025, three months to 2025-03-31−$27.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure(24.1)Operating income, Q2 FY2025, three months to 2025-06-30−$24.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure(20.9)Operating income, Q3 FY2025, three months to 2025-09-30−$20.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure(20.8)Operating income, Q4 FY2025, three months to 2025-12-31−$20.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-11, accession 0001193125-26-102252. Derived: 12-month figure less the 9-month figure.Report this figure(20.1)Operating income, Q1 FY2026, three months to 2026-03-31−$20.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure(44.1)Operating income, Q2 FY2026, three months to 2026-06-30−$44.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0000950170-24-122359. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-10, accession 0000950170-25-036329. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-07, accession 0000950170-25-065741.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0000950170-25-104182. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001193125-25-273239. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-11, accession 0001193125-26-102252. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001193125-25-273239. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-11, accession 0001193125-26-102252. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure
Net income$m(29.1)Net income, Q3 FY2023, three months to 2023-09-30−$29.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122359.Report this figure(29.9)Net income, Q4 FY2023, three months to 2023-12-31−$29.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-10, accession 0000950170-25-036329. Derived: 12-month figure less the 9-month figure.Report this figure(32.2)Net income, Q1 FY2024, three months to 2024-03-31−$32.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure(29.4)Net income, Q2 FY2024, three months to 2024-06-30−$29.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure(25.6)Net income, Q3 FY2024, three months to 2024-09-30−$25.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure(23.8)Net income, Q4 FY2024, three months to 2024-12-31−$23.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-11, accession 0001193125-26-102252. Derived: 12-month figure less the 9-month figure.Report this figure(26.9)Net income, Q1 FY2025, three months to 2025-03-31−$26.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure(23.3)Net income, Q2 FY2025, three months to 2025-06-30−$23.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure(20.3)Net income, Q3 FY2025, three months to 2025-09-30−$20.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure(20.2)Net income, Q4 FY2025, three months to 2025-12-31−$20.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-11, accession 0001193125-26-102252. Derived: 12-month figure less the 9-month figure.Report this figure(19.3)Net income, Q1 FY2026, three months to 2026-03-31−$19.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure(43.4)Net income, Q2 FY2026, three months to 2026-06-30−$43.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure
Diluted EPS$ per share(0.39)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0000950170-24-122359.Report this figurenot reported(0.40)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0000950170-25-065741.Report this figure(0.34)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0000950170-25-104182.Report this figure(0.30)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figurenot reported(0.24)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure(0.14)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure(0.12)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figurenot reported(0.09)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure(0.20)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure
Basic EPS$ per share(0.39)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0000950170-24-122359.Report this figurenot reported(0.40)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0000950170-25-065741.Report this figure(0.34)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0000950170-25-104182.Report this figure(0.30)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figurenot reported(0.24)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure(0.14)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure(0.12)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figurenot reported(0.09)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure(0.20)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure

Balance sheet

Cash and equivalents$78.1m, Q2 FY2026
Shareholders' equity$69.4m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m82.2Cash and equivalents, Q3 FY2023, at 2023-09-30$82.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0000950170-24-122359.Report this figure45.7Cash and equivalents, FY2023, at 2023-12-31$45.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-10, accession 0000950170-25-036329.Report this figure59.3Cash and equivalents, Q1 FY2024, at 2024-03-31$59.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0000950170-25-065741.Report this figure58.1Cash and equivalents, Q2 FY2024, at 2024-06-30$58.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0000950170-25-104182.Report this figure8.2Cash and equivalents, Q3 FY2024, at 2024-09-30$8.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure4.3Cash and equivalents, FY2024, at 2024-12-31$4.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-11, accession 0001193125-26-102252.Report this figure53.8Cash and equivalents, Q1 FY2025, at 2025-03-31$53.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure62.7Cash and equivalents, Q2 FY2025, at 2025-06-30$62.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure56.3Cash and equivalents, Q3 FY2025, at 2025-09-30$56.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure101Cash and equivalents, FY2025, at 2025-12-31$100.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure80.9Cash and equivalents, Q1 FY2026, at 2026-03-31$80.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure78.1Cash and equivalents, Q2 FY2026, at 2026-06-30$78.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure
Current assets$m127Current assets, Q3 FY2023, at 2023-09-30$126.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061162.Report this figure112Current assets, FY2023, at 2023-12-31$111.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-10, accession 0000950170-25-036329.Report this figure129Current assets, Q1 FY2024, at 2024-03-31$128.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059576.Report this figure105Current assets, Q2 FY2024, at 2024-06-30$105.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094059.Report this figure85.3Current assets, Q3 FY2024, at 2024-09-30$85.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122359.Report this figure67.4Current assets, FY2024, at 2024-12-31$67.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-11, accession 0001193125-26-102252.Report this figure94.5Current assets, Q1 FY2025, at 2025-03-31$94.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065741.Report this figure75.9Current assets, Q2 FY2025, at 2025-06-30$75.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0000950170-25-104182.Report this figure61.2Current assets, Q3 FY2025, at 2025-09-30$61.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure106Current assets, FY2025, at 2025-12-31$105.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure96.6Current assets, Q1 FY2026, at 2026-03-31$96.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure86.0Current assets, Q2 FY2026, at 2026-06-30$86.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure
Total assets$m193Total assets, Q3 FY2023, at 2023-09-30$193.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-061162.Report this figure171Total assets, FY2023, at 2023-12-31$170.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-10, accession 0000950170-25-036329.Report this figure185Total assets, Q1 FY2024, at 2024-03-31$184.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059576.Report this figure163Total assets, Q2 FY2024, at 2024-06-30$163.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-094059.Report this figure141Total assets, Q3 FY2024, at 2024-09-30$140.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0000950170-24-122359.Report this figure120Total assets, FY2024, at 2024-12-31$119.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-11, accession 0001193125-26-102252.Report this figure144Total assets, Q1 FY2025, at 2025-03-31$144.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0000950170-25-065741.Report this figure122Total assets, Q2 FY2025, at 2025-06-30$122.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0000950170-25-104182.Report this figure105Total assets, Q3 FY2025, at 2025-09-30$105.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure147Total assets, FY2025, at 2025-12-31$146.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure135Total assets, Q1 FY2026, at 2026-03-31$135.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure93.5Total assets, Q2 FY2026, at 2026-06-30$93.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure
Current liabilities$m19.4Current liabilities, Q3 FY2023, at 2023-09-30$19.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061162.Report this figure22.7Current liabilities, FY2023, at 2023-12-31$22.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-10, accession 0000950170-25-036329.Report this figure19.2Current liabilities, Q1 FY2024, at 2024-03-31$19.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059576.Report this figure16.7Current liabilities, Q2 FY2024, at 2024-06-30$16.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094059.Report this figure16.2Current liabilities, Q3 FY2024, at 2024-09-30$16.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122359.Report this figure16.0Current liabilities, FY2024, at 2024-12-31$16.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-11, accession 0001193125-26-102252.Report this figure14.2Current liabilities, Q1 FY2025, at 2025-03-31$14.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065741.Report this figure12.7Current liabilities, Q2 FY2025, at 2025-06-30$12.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0000950170-25-104182.Report this figure13.2Current liabilities, Q3 FY2025, at 2025-09-30$13.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure15.4Current liabilities, FY2025, at 2025-12-31$15.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure16.8Current liabilities, Q1 FY2026, at 2026-03-31$16.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure19.0Current liabilities, Q2 FY2026, at 2026-06-30$19.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure
Total liabilities$m28.5Total liabilities, Q3 FY2023, at 2023-09-30$28.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0000950170-23-061162.Report this figure31.1Total liabilities, FY2023, at 2023-12-31$31.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-10, accession 0000950170-25-036329.Report this figure26.7Total liabilities, Q1 FY2024, at 2024-03-31$26.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0000950170-24-059576.Report this figure29.2Total liabilities, Q2 FY2024, at 2024-06-30$29.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-094059.Report this figure28.0Total liabilities, Q3 FY2024, at 2024-09-30$28.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0000950170-24-122359.Report this figure27.1Total liabilities, FY2024, at 2024-12-31$27.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-11, accession 0001193125-26-102252.Report this figure24.6Total liabilities, Q1 FY2025, at 2025-03-31$24.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-07, accession 0000950170-25-065741.Report this figure22.3Total liabilities, Q2 FY2025, at 2025-06-30$22.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0000950170-25-104182.Report this figure22.1Total liabilities, Q3 FY2025, at 2025-09-30$22.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure23.7Total liabilities, FY2025, at 2025-12-31$23.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure28.9Total liabilities, Q1 FY2026, at 2026-03-31$28.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure24.1Total liabilities, Q2 FY2026, at 2026-06-30$24.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure
Shareholders' equity$m165Shareholders' equity, Q3 FY2023, at 2023-09-30$164.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0000950170-24-122359.Report this figure139Shareholders' equity, FY2023, at 2023-12-31$139.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-11, accession 0001193125-26-102252.Report this figure158Shareholders' equity, Q1 FY2024, at 2024-03-31$158.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure134Shareholders' equity, Q2 FY2024, at 2024-06-30$134.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure113Shareholders' equity, Q3 FY2024, at 2024-09-30$112.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure92.9Shareholders' equity, FY2024, at 2024-12-31$92.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure119Shareholders' equity, Q1 FY2025, at 2025-03-31$119.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure99.8Shareholders' equity, Q2 FY2025, at 2025-06-30$99.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure82.9Shareholders' equity, Q3 FY2025, at 2025-09-30$82.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure123Shareholders' equity, FY2025, at 2025-12-31$123.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure106Shareholders' equity, Q1 FY2026, at 2026-03-31$106.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure69.4Shareholders' equity, Q2 FY2026, at 2026-06-30$69.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure

Cash flow

Operating cash flow−$3.6m, Q2 FY2026
Capital expenditure$159.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(23.6)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$23.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0000950170-24-122359. Derived: 9-month figure less the 6-month figure.Report this figure(21.9)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$21.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-10, accession 0000950170-25-036329. Derived: 12-month figure less the 9-month figure.Report this figure(28.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$28.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0000950170-25-065741.Report this figure(23.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$23.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0000950170-25-104182. Derived: 6-month figure less the 3-month figure.Report this figure(19.8)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$19.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-273239. Derived: 9-month figure less the 6-month figure.Report this figure(18.4)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$18.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-11, accession 0001193125-26-102252. Derived: 12-month figure less the 9-month figure.Report this figure(23.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$23.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure(15.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$15.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-335140. Derived: 6-month figure less the 3-month figure.Report this figure(15.6)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$15.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-273239. Derived: 9-month figure less the 6-month figure.Report this figure(13.9)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$13.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-11, accession 0001193125-26-102252. Derived: 12-month figure less the 9-month figure.Report this figure(19.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$19.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure(3.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$3.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-335140. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$8.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0000950170-24-122359. Derived: 9-month figure less the 6-month figure.Report this figure0.4Capital expenditure, Q4 FY2023, three months to 2023-12-31$394.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-10, accession 0000950170-25-036329. Derived: 12-month figure less the 9-month figure.Report this figure0.6Capital expenditure, Q1 FY2024, three months to 2024-03-31$564.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-07, accession 0000950170-25-065741.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$73.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0000950170-25-104182. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$184.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-273239. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$204.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-11, accession 0001193125-26-102252. Derived: 12-month figure less the 9-month figure.Report this figure0.4Capital expenditure, Q1 FY2025, three months to 2025-03-31$383.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$142.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-335140. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$26.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-273239. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$67.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-11, accession 0001193125-26-102252. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$11.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure0.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$159.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-335140. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)217.57m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares41.4Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3041,358,296 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0000950170-23-061162.Report this figure73.1Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3173,097,889 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0000950170-24-059576.Report this figure73.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3073,399,847 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-094059.Report this figure73.9Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3073,924,937 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0000950170-24-122359.Report this figure81.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3180,982,326 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0000950170-25-065741.Report this figure85.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3085,706,501 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0000950170-25-104182.Report this figure86.2Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3086,162,841 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure110Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31109,869,278 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure163Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30162,791,579 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure163Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30163,345,972 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-273239.Report this figure217Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31216,883,164 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001193125-26-209084.Report this figure218Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30217,574,637 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure

Shares outstanding: 224.23mShares outstanding, period not labelled, at 2026-07-30224,230,012 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335140.Report this figure at Jul 30, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.